Gayle Furgurson Wellborn - 12 Dec 2025 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Reporting relationship: Director
Issuer ticker: HQY
Reported as of: 12 Dec 2025
Net transaction value: -$206,602
SEC form: 4
Accepted by SEC: 16 Dec 2025, 15:44:01 UTC
Prior SEC filing: 30 Jun 2025
Next SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Newton, Attorney-in-Fact

Key filing fact

Gayle Furgurson Wellborn filed Form 4 for HEALTHEQUITY, INC. (HQY) on 16 Dec 2025.

Key facts

This page summarizes Gayle Furgurson Wellborn's Form 4 filing for HEALTHEQUITY, INC. (HQY).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 16 Dec 2025, 15:44.

Change

Previous filing in this sequence was filed on 30 Jun 2025.
Current net transaction value: -$206,602.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001712960 Primary reporting owner

Wellborn Gayle Furgurson

Relationship: Director
Address: C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER
Signature: /s/ Michael Newton, Attorney-in-Fact
Signature date: 16 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HQY transaction

Common Stock

Options Exercise

Transaction value: $218,729
Shares: +4,339
Change %: +22%
Price: $50.41
Shares after: 24,072
Date: 12 Dec 2025
Ownership: Direct

HQY transaction

Common Stock

Sale

Transaction value: $425,331
Shares: -4,339
Change %: -18%
Price: $98.03
Shares after: 19,733
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HQY transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value: $0
Shares: -4,339
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,339
Exercise price: $50.41
Footnotes: F2

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,439
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,439
Exercise price: $47.21
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.87 to $98.20 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

Footnote F2

The option is immediately exercisable.

SEC remarks

The Power of Attorney given by Ms. Wellborn was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023, as an exhibit to a statement on Form 4 filed by Ms. Wellborn with respect to HealthEquity, Inc. and is hereby incorporated by reference.